nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—PON3—parotid gland—salivary gland cancer	0.0258	0.0995	CbGeAlD
Lovastatin—PON3—saliva-secreting gland—salivary gland cancer	0.0247	0.0953	CbGeAlD
Lovastatin—ITGAL—connective tissue—salivary gland cancer	0.0232	0.0893	CbGeAlD
Lovastatin—HDAC2—tongue—salivary gland cancer	0.0225	0.0866	CbGeAlD
Lovastatin—ITGAL—epithelium—salivary gland cancer	0.022	0.0848	CbGeAlD
Lovastatin—ITGAL—lymphoid tissue—salivary gland cancer	0.017	0.0653	CbGeAlD
Lovastatin—HDAC2—neck—salivary gland cancer	0.0129	0.0498	CbGeAlD
Lovastatin—HMGCR—neck—salivary gland cancer	0.0117	0.0449	CbGeAlD
Lovastatin—HDAC2—saliva-secreting gland—salivary gland cancer	0.0101	0.0388	CbGeAlD
Lovastatin—ITGAL—lymph node—salivary gland cancer	0.00957	0.0368	CbGeAlD
Lovastatin—HMGCR—parotid gland—salivary gland cancer	0.0095	0.0366	CbGeAlD
Lovastatin—HDAC2—connective tissue—salivary gland cancer	0.00927	0.0357	CbGeAlD
Lovastatin—HMGCR—saliva-secreting gland—salivary gland cancer	0.0091	0.0351	CbGeAlD
Lovastatin—HDAC2—epithelium—salivary gland cancer	0.0088	0.0339	CbGeAlD
Lovastatin—HMGCR—connective tissue—salivary gland cancer	0.00836	0.0322	CbGeAlD
Lovastatin—HMGCR—epithelium—salivary gland cancer	0.00794	0.0306	CbGeAlD
Lovastatin—HDAC2—lymphoid tissue—salivary gland cancer	0.00678	0.0261	CbGeAlD
Lovastatin—HMGCR—lymphoid tissue—salivary gland cancer	0.00612	0.0235	CbGeAlD
Lovastatin—HDAC2—lymph node—salivary gland cancer	0.00382	0.0147	CbGeAlD
Lovastatin—HMGCR—lymph node—salivary gland cancer	0.00345	0.0133	CbGeAlD
Lovastatin—ABCC2—lymph node—salivary gland cancer	0.00251	0.00965	CbGeAlD
Lovastatin—ABCB1—epithelium—salivary gland cancer	0.00207	0.00799	CbGeAlD
Lovastatin—ABCB1—lymphoid tissue—salivary gland cancer	0.0016	0.00615	CbGeAlD
Lovastatin—ABCB1—lymph node—salivary gland cancer	0.000901	0.00347	CbGeAlD
Lovastatin—UGT1A3—Metabolism—ST3GAL4—salivary gland cancer	0.000519	0.000701	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—CCND1—salivary gland cancer	0.00051	0.000689	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ISYNA1—salivary gland cancer	0.000507	0.000685	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000505	0.000682	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—EP300—salivary gland cancer	0.0005	0.000675	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000497	0.000671	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAML3—salivary gland cancer	0.000496	0.00067	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MARCKS—salivary gland cancer	0.000491	0.000664	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PYGB—salivary gland cancer	0.00049	0.000661	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—salivary gland cancer	0.000489	0.00066	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—salivary gland cancer	0.000477	0.000645	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NUP62—salivary gland cancer	0.000471	0.000637	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AQP1—salivary gland cancer	0.000471	0.000636	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—EP300—salivary gland cancer	0.00047	0.000635	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HRAS—salivary gland cancer	0.000459	0.000621	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—NUP62—salivary gland cancer	0.000458	0.000619	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PHGDH—salivary gland cancer	0.000458	0.000619	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PYGB—salivary gland cancer	0.000457	0.000617	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF16—salivary gland cancer	0.000456	0.000616	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—VCAN—salivary gland cancer	0.000455	0.000614	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MARCKS—salivary gland cancer	0.00045	0.000608	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MC3R—salivary gland cancer	0.000442	0.000597	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ST3GAL4—salivary gland cancer	0.000441	0.000596	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NUP62—salivary gland cancer	0.000438	0.000591	CbGpPWpGaD
Lovastatin—HDAC2—Disease—VCAN—salivary gland cancer	0.000434	0.000586	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—PTEN—salivary gland cancer	0.000427	0.000577	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MAML2—salivary gland cancer	0.000427	0.000577	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000425	0.000575	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000422	0.00057	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PYGB—salivary gland cancer	0.000419	0.000566	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MARCKS—salivary gland cancer	0.000413	0.000558	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EP300—salivary gland cancer	0.000407	0.00055	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AQP1—salivary gland cancer	0.000401	0.000541	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PHGDH—salivary gland cancer	0.000399	0.000539	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000399	0.000539	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAML2—salivary gland cancer	0.000396	0.000535	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—PTEN—salivary gland cancer	0.000395	0.000534	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SMC1A—salivary gland cancer	0.000394	0.000533	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000394	0.000532	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DTX4—salivary gland cancer	0.000386	0.000522	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PYGB—salivary gland cancer	0.000384	0.000519	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000384	0.000519	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—NUP62—salivary gland cancer	0.000374	0.000505	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PHGDH—salivary gland cancer	0.000372	0.000503	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—VCAN—salivary gland cancer	0.000371	0.000501	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ISYNA1—salivary gland cancer	0.000366	0.000495	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ST3GAL4—salivary gland cancer	0.000359	0.000484	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—salivary gland cancer	0.000357	0.000483	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—CREBBP—salivary gland cancer	0.00035	0.000473	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AQP1—salivary gland cancer	0.000349	0.000471	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PHGDH—salivary gland cancer	0.000341	0.000461	CbGpPWpGaD
Lovastatin—HDAC2—Disease—JAG1—salivary gland cancer	0.000338	0.000457	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGFR4—salivary gland cancer	0.000337	0.000455	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FBXW7—salivary gland cancer	0.000332	0.000448	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ST3GAL4—salivary gland cancer	0.000329	0.000444	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AQP1—salivary gland cancer	0.000326	0.00044	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF16—salivary gland cancer	0.00032	0.000432	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000319	0.000431	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NUP62—salivary gland cancer	0.000318	0.000429	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ISYNA1—salivary gland cancer	0.000317	0.000429	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—VCAN—salivary gland cancer	0.000315	0.000426	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PHGDH—salivary gland cancer	0.000313	0.000423	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ST3GAL4—salivary gland cancer	0.000302	0.000407	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—PIK3CA—salivary gland cancer	0.000301	0.000407	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MARCKS—salivary gland cancer	0.000299	0.000404	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AQP1—salivary gland cancer	0.000298	0.000403	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000285	0.000385	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000284	0.000384	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ISYNA1—salivary gland cancer	0.000283	0.000383	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FOXO3—salivary gland cancer	0.00028	0.000378	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—PIK3CA—salivary gland cancer	0.000279	0.000376	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HRAS—salivary gland cancer	0.000279	0.000376	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PYGB—salivary gland cancer	0.000278	0.000375	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAML2—salivary gland cancer	0.000278	0.000375	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NUP62—salivary gland cancer	0.000277	0.000374	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000277	0.000374	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—VCAN—salivary gland cancer	0.000274	0.000371	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AQP1—salivary gland cancer	0.000274	0.00037	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000272	0.000367	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000261	0.000352	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MARCKS—salivary gland cancer	0.000259	0.00035	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ISYNA1—salivary gland cancer	0.000258	0.000349	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NUP62—salivary gland cancer	0.000258	0.000349	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—HRAS—salivary gland cancer	0.000258	0.000348	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—VCAN—salivary gland cancer	0.000256	0.000346	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000253	0.000342	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000247	0.000334	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000241	0.000325	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PYGB—salivary gland cancer	0.000241	0.000325	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—EP300—salivary gland cancer	0.000239	0.000322	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—JAG1—salivary gland cancer	0.000237	0.00032	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NUP62—salivary gland cancer	0.000237	0.00032	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGFR4—salivary gland cancer	0.000236	0.000319	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—VCAN—salivary gland cancer	0.000235	0.000317	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FBXW7—salivary gland cancer	0.000232	0.000314	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MARCKS—salivary gland cancer	0.000231	0.000312	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000229	0.000309	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAP2K2—salivary gland cancer	0.000228	0.000308	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PHGDH—salivary gland cancer	0.000226	0.000306	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000225	0.000305	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	0.000218	0.000294	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NUP62—salivary gland cancer	0.000217	0.000293	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—VCAN—salivary gland cancer	0.000215	0.000291	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PYGB—salivary gland cancer	0.000215	0.00029	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000212	0.000287	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MARCKS—salivary gland cancer	0.000211	0.000284	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PYGB—salivary gland cancer	0.00021	0.000283	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000209	0.000282	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000206	0.000278	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NOTCH1—salivary gland cancer	0.000202	0.000272	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000201	0.000272	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AQP1—salivary gland cancer	0.000198	0.000267	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000198	0.000267	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PHGDH—salivary gland cancer	0.000196	0.000265	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FOXO3—salivary gland cancer	0.000196	0.000265	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000196	0.000265	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PYGB—salivary gland cancer	0.000196	0.000264	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	0.000189	0.000255	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOTCH1—salivary gland cancer	0.000187	0.000253	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—CREBBP—salivary gland cancer	0.000183	0.000247	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000183	0.000247	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CREBBP—salivary gland cancer	0.000178	0.00024	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PIK3CA—salivary gland cancer	0.000177	0.000238	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000176	0.000238	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PHGDH—salivary gland cancer	0.000175	0.000236	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000172	0.000232	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AQP1—salivary gland cancer	0.000171	0.000232	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000171	0.000231	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—salivary gland cancer	0.000171	0.000231	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.00017	0.00023	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CREBBP—salivary gland cancer	0.00017	0.000229	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ST3GAL4—salivary gland cancer	0.000168	0.000228	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000168	0.000227	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000164	0.000222	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000164	0.000222	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HRAS—salivary gland cancer	0.000163	0.000221	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000161	0.000217	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAP2K2—salivary gland cancer	0.00016	0.000216	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PHGDH—salivary gland cancer	0.00016	0.000216	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000157	0.000212	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000156	0.00021	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000155	0.000209	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	0.000154	0.000208	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AQP1—salivary gland cancer	0.000153	0.000207	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000149	0.000202	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000147	0.000199	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CREBBP—salivary gland cancer	0.000145	0.000196	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000141	0.00019	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00014	0.000189	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AQP1—salivary gland cancer	0.00014	0.000188	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000139	0.000188	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NUP62—salivary gland cancer	0.000136	0.000184	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—VCAN—salivary gland cancer	0.000135	0.000182	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOTCH1—salivary gland cancer	0.000131	0.000177	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000129	0.000174	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTEN—salivary gland cancer	0.000127	0.000171	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000124	0.000168	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CREBBP—salivary gland cancer	0.000123	0.000166	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000121	0.000164	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NUP62—salivary gland cancer	0.000121	0.000164	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTEN—salivary gland cancer	0.000121	0.000164	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—EP300—salivary gland cancer	0.000121	0.000164	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—VCAN—salivary gland cancer	0.00012	0.000163	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00012	0.000163	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CREBBP—salivary gland cancer	0.000119	0.00016	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000118	0.00016	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000118	0.00016	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000117	0.000159	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EP300—salivary gland cancer	0.000116	0.000156	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000112	0.000151	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000111	0.00015	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NUP62—salivary gland cancer	0.000111	0.000149	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—VCAN—salivary gland cancer	0.00011	0.000148	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CREBBP—salivary gland cancer	0.000107	0.000145	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000106	0.000143	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000105	0.000142	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000104	0.00014	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTEN—salivary gland cancer	0.000103	0.00014	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000101	0.000137	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CREBBP—salivary gland cancer	0.0001	0.000135	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—EP300—salivary gland cancer	9.87e-05	0.000133	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	9.8e-05	0.000132	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	9.63e-05	0.00013	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AQP1—salivary gland cancer	9.2e-05	0.000124	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CREBBP—salivary gland cancer	9.17e-05	0.000124	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—salivary gland cancer	8.95e-05	0.000121	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—salivary gland cancer	8.8e-05	0.000119	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—salivary gland cancer	8.79e-05	0.000119	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—salivary gland cancer	8.55e-05	0.000115	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—salivary gland cancer	8.48e-05	0.000115	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.45e-05	0.000114	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CREBBP—salivary gland cancer	8.42e-05	0.000114	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—EP300—salivary gland cancer	8.39e-05	0.000113	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EP300—salivary gland cancer	8.09e-05	0.000109	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.06e-05	0.000109	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—salivary gland cancer	7.91e-05	0.000107	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—salivary gland cancer	7.66e-05	0.000103	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.54e-05	0.000102	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—EP300—salivary gland cancer	7.31e-05	9.87e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—salivary gland cancer	7.3e-05	9.86e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NUP62—salivary gland cancer	7.3e-05	9.86e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—VCAN—salivary gland cancer	7.24e-05	9.78e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.2e-05	9.72e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—salivary gland cancer	7.15e-05	9.66e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	6.88e-05	9.29e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—EP300—salivary gland cancer	6.82e-05	9.21e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	6.56e-05	8.86e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—salivary gland cancer	6.55e-05	8.85e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—EP300—salivary gland cancer	6.25e-05	8.44e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—salivary gland cancer	6.21e-05	8.38e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CREBBP—salivary gland cancer	6.09e-05	8.22e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—salivary gland cancer	6.01e-05	8.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—salivary gland cancer	5.99e-05	8.08e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.96e-05	8.05e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—salivary gland cancer	5.79e-05	7.82e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—EP300—salivary gland cancer	5.73e-05	7.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—salivary gland cancer	5.54e-05	7.48e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—salivary gland cancer	5.4e-05	7.3e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.32e-05	7.19e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CREBBP—salivary gland cancer	5.27e-05	7.12e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—salivary gland cancer	5.04e-05	6.81e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.85e-05	6.56e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CREBBP—salivary gland cancer	4.7e-05	6.36e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—salivary gland cancer	4.62e-05	6.24e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CREBBP—salivary gland cancer	4.59e-05	6.2e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—salivary gland cancer	4.35e-05	5.87e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CREBBP—salivary gland cancer	4.33e-05	5.85e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CREBBP—salivary gland cancer	4.29e-05	5.79e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	4.24e-05	5.73e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—EP300—salivary gland cancer	4.14e-05	5.6e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—salivary gland cancer	3.76e-05	5.08e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—EP300—salivary gland cancer	3.59e-05	4.85e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—salivary gland cancer	3.36e-05	4.54e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—salivary gland cancer	3.28e-05	4.43e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—EP300—salivary gland cancer	3.2e-05	4.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—EP300—salivary gland cancer	3.13e-05	4.22e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—salivary gland cancer	3.09e-05	4.17e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	3.07e-05	4.14e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—salivary gland cancer	3.06e-05	4.14e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—EP300—salivary gland cancer	2.95e-05	3.98e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—EP300—salivary gland cancer	2.92e-05	3.95e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CREBBP—salivary gland cancer	2.83e-05	3.82e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	2.66e-05	3.59e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—salivary gland cancer	2.37e-05	3.2e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—salivary gland cancer	2.31e-05	3.13e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	2.18e-05	2.94e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	2.16e-05	2.92e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.02e-05	2.73e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—EP300—salivary gland cancer	1.93e-05	2.6e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.43e-05	1.93e-05	CbGpPWpGaD
